Table of Contents

company-logo

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.

Accelerate Diagnostics Dividend Announcement

• Accelerate Diagnostics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Accelerate Diagnostics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Accelerate Diagnostics Dividend History

Accelerate Diagnostics Dividend Yield

Accelerate Diagnostics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Accelerate Diagnostics stock? Use our calculator to estimate your expected dividend yield:

Accelerate Diagnostics Financial Ratios

P/E ratio-0.76
PEG ratio0.07
P/B ratio-0.84
ROE165.71%
Payout ratio0.00%
Current ratio1.50
Quick ratio1.34
Cash Ratio1.08

Accelerate Diagnostics Dividend FAQ

Does Accelerate Diagnostics stock pay dividends?
Accelerate Diagnostics does not currently pay dividends to its shareholders.
Has Accelerate Diagnostics ever paid a dividend?
No, Accelerate Diagnostics has no a history of paying dividends to its shareholders. Accelerate Diagnostics is not known for its dividend payments.
Why doesn't Accelerate Diagnostics pay dividends?
There are several potential reasons why Accelerate Diagnostics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Accelerate Diagnostics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Accelerate Diagnostics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Accelerate Diagnostics a dividend aristocrat?
Accelerate Diagnostics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Accelerate Diagnostics a dividend king?
Accelerate Diagnostics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Accelerate Diagnostics a dividend stock?
No, Accelerate Diagnostics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Accelerate Diagnostics stocks?
To buy Accelerate Diagnostics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Accelerate Diagnostics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.